Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133(+) Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy

According to the European Medicine Agency (EMA) regulatory frameworks, Advanced Therapy Medicinal Products (ATMP) represent a new category of drugs in which the active ingredient consists of cells, genes, or tissues. ATMP-CD133 has been widely investigated in controlled clinical trials for cardiovas...

Descripción completa

Detalles Bibliográficos
Autores principales: Belotti, Daniela, Gaipa, Giuseppe, Bassetti, Beatrice, Cabiati, Benedetta, Spaltro, Gabriella, Biagi, Ettore, Parma, Matteo, Biondi, Andrea, Cavallotti, Laura, Gambini, Elisa, Pompilio, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606188/
https://www.ncbi.nlm.nih.gov/pubmed/26495296
http://dx.doi.org/10.1155/2015/473159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606188/
https://www.ncbi.nlm.nih.gov/pubmed/26495296
http://dx.doi.org/10.1155/2015/473159

Ejemplares similares